Jacobio Pharma Presented Preliminary Data On BET Inhibitor For Myelofibrosis At 2024 ASH
Jacobio Pharma Presented Preliminary Data On BET Inhibitor For Myelofibrosis At 2024 ASH . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167), a clinical-stage oncology company dedicated to developing therapies toward ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108969225/Jacobio-Pharma-Presented-Preliminary-Data-On-BET-Inhibitor-For-Myelofibrosis-At-2024-ASH
2024-12-08
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167), a clinical-stage oncology company dedicated to developing therapies toward ...
Jacobio Pharma Presented Preliminary Data On BET Inhibitor For Myelofibrosis At 2024 ASH